Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.16

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.16. Revenue for the quarter came in at $10.9 million, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Pfizer reaffirms 2026 guidance after CFO transition news
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group